Cargando…

Efficacy and Safety of Heterologous Booster Vaccination after Ad5-nCoV (CanSino Biologics) Vaccine: A Preliminary Descriptive Study

Several studies have reported the benefits and safety of heterologous vaccination among different approved vaccines; however, there are no specific reports on the effects of vaccination with the Ad5-nCoV and other vaccines of the same or different technologies. In the present study, we evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz-Valle, José Francisco, Sánchez-Zuno, Gabriela Athziri, Matuz-Flores, Mónica Guadalupe, Hernández-Ramírez, Cristian Oswaldo, Díaz-Pérez, Saúl Alberto, Baños-Hernández, Christian Johana, Turrubiates-Hernández, Francisco Javier, Vega-Magaña, Alejandra Natali, Hernández-Bello, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954152/ https://www.ncbi.nlm.nih.gov/pubmed/35335032 http://dx.doi.org/10.3390/vaccines10030400

Ejemplares similares

Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2
por: Hernández-Bello, Jorge, et al.
Publicado: (2021)

IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population
por: Guzmán-Martínez, Oscar, et al.
Publicado: (2021)

CanSino COVID-19 Vaccine: Comparison of Vaccine Adverse Effects Among Diabetic and Non-diabetic Recipients
por: Abualhamael, Shahad Abduljalil, et al.
Publicado: (2023)

A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
por: Sánchez-Zuno, Gabriela Athziri, et al.
Publicado: (2021)

Vitamin D Levels in COVID-19 Outpatients from Western Mexico: Clinical Correlation and Effect of Its Supplementation
por: Sánchez-Zuno, Gabriela Athziri, et al.
Publicado: (2021)

Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: An ally for Latin America (Review)
por: Turrubiates-Hernández, Francisco Javier, et al.
Publicado: (2021)

Association of Food Intake Quality with Vitamin D in SARS-CoV-2 Positive Patients from Mexico: A Cross-Sectional Study
por: González-Estevez, Guillermo, et al.
Publicado: (2021)

Clinical and Immunologic Efficacy of the Recombinant Adenovirus Type-5-Vectored (CanSino Bio) Vaccine in University Professors during the COVID-19 Delta Wave
por: Guzmán-López, Santos, et al.
Publicado: (2022)

Effect of Heterologous Vaccination Regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG Antibodies Titers †
por: Romero-Ibarguengoitia, Maria Elena, et al.
Publicado: (2022)

PADI4 Haplotypes Contribute to mRNA Expression, the Enzymatic Activity of Peptidyl Arginine Deaminase and Rheumatoid Arthritis Risk in Patients from Western Mexico
por: Matuz-Flores, Mónica Guadalupe, et al.
Publicado: (2022)

Homologous and Heterologous Covid-19 Booster Vaccinations
por: Atmar, Robert L., et al.
Publicado: (2022)

The Novel Role of MIF in the Secretion of IL-25, IL-31, and IL-33 from PBMC of Patients with Rheumatoid Arthritis
por: García-Arellano, Samuel, et al.
Publicado: (2021)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
por: Goh, Yun Shan, et al.
Publicado: (2022)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
Publicado: (2023)

Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination
por: Zhao, Weijun, et al.
Publicado: (2022)

Heterologous vaccine interventions: boosting immunity against future pandemics
por: Marín-Hernández, Daniela, et al.
Publicado: (2021)

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report
por: Atmar, Robert L., et al.
Publicado: (2021)

Commentary: Long Non-Coding RNA Gene Polymorphisms and Their Expression Levels in Patients With Rheumatoid Arthritis
por: Hernández-Bello, Jorge, et al.
Publicado: (2021)

Neutralization of Omicron BA.1, BA.5.1.6, BQ.1.3 and XBB1.1 induced by heterologous vaccination Ad5-nCoV and mRNA-1273
por: Hernández, Jesús, et al.
Publicado: (2023)

Canonical (CD74/CD44) and Non-Canonical (CXCR2, 4 and 7) MIF Receptors Are Differentially Expressed in Rheumatoid Arthritis Patients Evaluated by DAS28-ESR
por: Sánchez-Zuno, Gabriela Athziri, et al.
Publicado: (2021)

Heterologous booster COVID-19 vaccination elicited potent immune responses in HCWs
por: Saltoğlu, Neşe, et al.
Publicado: (2022)

Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile
por: Acevedo, Johanna, et al.
Publicado: (2023)

Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
por: Park, Seon Kyeong, et al.
Publicado: (2023)

Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
por: Normark, Johan, et al.
Publicado: (2021)

La pléyade jalisciense del Federalismo y la Reforma /
por: Zuno Hernández, José Guadalupe, 1891-1980
Publicado: (1967)

Historia de la Revolución en el Estado de Jalisco
por: Zuno Hernández, José Guadalupe, 1891-1980
Publicado: (1964)

La muerte de Juárez : drama histórico
por: Zuno Hernández, José Guadalupe, 1891-1980
Publicado: (1962)

Historia de la caricatura en México
por: Zuno Hernández, José Guadalupe, 1891-1980
Publicado: (1961)

Nuestro liberalismo
por: Zuno Hernández, José Guadalupe, 1891-1980
Publicado: (1956)

Las llamadas lacas michoacanas de Uruapan no procedentes de las orientales = The called michoacanas lacquers of Uruapan dont't proced of the orientals
por: Zuno Hernández, José Guadalupe, 1891-1980
Publicado: (1958)

Reminiscencias de una vida
por: Zuno Hernández, José Guadalupe, 1891-1980

Las artes plásticas en Jalisco : ensayo crítico-histórico /
por: Zuno Hernández, José Guadalupe, 1891-1980
Publicado: (1957)

Historia de las Artes Plásticas en la Revolución Mexicana
por: Zuno Hernández, José Guadalupe, 1891-1980
Publicado: (1967)

Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report
por: Intapiboon, Porntip, et al.
Publicado: (2023)

Booster or additional vaccination doses in patients vaccinated against COVID-19
por: García-Botella, Alejandra, et al.
Publicado: (2021)

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
por: Schmidt, Tina, et al.
Publicado: (2021)

Heterologous COVID-19 Booster Vaccination in the Chronic Disorder of Consciousness: A Pilot Study
por: Pugliese, Maria Elena, et al.
Publicado: (2022)

Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
por: Ranzani, Otavio T., et al.
Publicado: (2022)

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines
por: Cohen, Guy, et al.
Publicado: (2022)

Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes
por: Hu, Yuxuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9a00h4qggoq31792ve006lq54g